Q2 2022

Source filing unavailable

Q2 2022 · —

Revenue—

Net Income

-$42.06M

no prior Q2 2021 on file

EPS Diluted

-$0.46

no prior Q2 2021 on file

Operating Income-$39,063,000—

Same quarter

Metric	Q2 2022	Q2 2020	Q2 2019	Q2 2018
Revenue	—	$293.00K	$338.00K	$443.00K
Net Income	-$42.06M	-$32.05M	-$28.48M	-$7.65M
EPS Diluted	-$0.46	-$0.62	-$0.65	-$0.26

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR